Galapagos NV Files Form 6-K with Press Release
Ticker: GLPGF · Form: 6-K · Filed: Sep 3, 2024 · CIK: 1421876
| Field | Detail |
|---|---|
| Company | Galapagos NV (GLPGF) |
| Form Type | 6-K |
| Filed Date | Sep 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, press-release, corporate-update
TL;DR
Galapagos NV filed a 6-K on Sept 3rd, incorporating a press release. Check for updates.
AI Summary
On September 3, 2024, Galapagos NV filed a Form 6-K to incorporate by reference a press release issued on the same date. This filing is part of their ongoing reporting obligations and is incorporated into several of their existing Form S-8 registration statements.
Why It Matters
This filing signals ongoing corporate activity and regulatory compliance for Galapagos NV, potentially including updates relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing (Form 6-K) that incorporates a press release, indicating standard corporate reporting rather than a significant event.
Key Players & Entities
- GALAPAGOS NV (company) — Registrant
- September 3, 2024 (date) — Date of press release and filing
- Form 6-K (document) — Type of SEC filing
- Exhibit 99.1 (document) — Incorporated press release
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to incorporate by reference a press release issued by Galapagos NV on September 3, 2024, as Exhibit 99.1.
What is the filing date of this Form 6-K?
The filing date is September 3, 2024.
What other SEC filings does this Form 6-K reference?
This Form 6-K is incorporated by reference into Galapagos NV's Registration Statements on Form S-8, specifically listing File Nos. 333-204567 through 333-275886.
Where is Galapagos NV located?
Galapagos NV's principal executive office is located at Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium.
What type of company is Galapagos NV?
Galapagos NV is classified under the Standard Industrial Classification code 2834, which is Pharmaceutical Preparations.
Filing Stats: 209 words · 1 min read · ~1 pages · Grade level 11.5 · Accepted 2024-09-03 17:17:58
Filing Documents
- f6k_090324.htm (6-K) — 4KB
- exh_991.htm (EX-99.1) — 4KB
- 0001171843-24-005034.txt ( ) — 9KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GALAPAGOS NV (Registrant) Date: September 3, 2024 /s/ Annelies Denecker Annelies Denecker Company Secretary